Quickcare-Morgantown is categorized under Internal Medicine Doctors in Reading, PA and active since 2009.
Quickcare-Morgantown was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Marsha Noecker at the company’s single location by writing to 950b North Wyomissing Boulevard F1, Reading, Pennsylvania PA 19610 or by phoning (610) 898-7576. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Quickcare-Morgantown |
| Contact Person: | Marsha Noecker |
| Address: | 950b North Wyomissing Boulevard F1, Reading, Pennsylvania 19610 |
| Phone Number: | (610) 898-7576 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Quickcare-Morgantown was started in 2009 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Marsha Noecker for inquiries that concern Quickcare-Morgantown by calling the company number (610) 898-7576, as your correspondence is most welcome. Additionally, the physical location of the single location of Quickcare-Morgantown can be found at the coordinates 40.339531,-75.963722 as well as the street address 950b North Wyomissing Boulevard F1 in Reading, Pennsylvania 19610.
For its online presence, you may visit Quickcare-Morgantown’s website at and engage with its social media outlets through on Twitter and on Facebook.